Instil Bio, Inc.
TIL
$7.98
$0.000.00%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/15/2026
-
Globe Newswire
4/20/2026
-
Globe Newswire
3/28/2026
-
TipRanks Financial Blog
3/28/2026
-
TipRanks Financial Blog
3/27/2026
-
Seeking Alpha - Healthcare
3/27/2026
-
SeekingAlpha.com: All News
Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
3/27/2026
-
Globe Newswire
2/12/2026
-
PR Newswire
2/3/2026
-
Globe Newswire
1/29/2026
-
GuruFocus
1/29/2026
-
PR Newswire
1/27/2026
-
GuruFocus
1/27/2026
-
Globe Newswire
1/22/2026
-
GuruFocus
1/22/2026
-
PR Newswire
1/20/2026
-
GuruFocus
1/20/2026
-
Globe Newswire
1/15/2026
-
GuruFocus
1/15/2026
-
PR Newswire
1/13/2026
-
GuruFocus
1/13/2026
-
Globe Newswire
1/9/2026
-
GuruFocus
1/9/2026
-
PR Newswire
1/7/2026
-
GuruFocus
1/7/2026
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, May 15, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 499 3350
Address
3963 Maple Avenue
Dallas, TX 75219
Dallas, TX 75219
Country
Year Founded
Business Description
Sector
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic...
more